Announced Thu, 4 Jun · 15:00 IST
Natco Pharma Limited has informed the Exchange about Transcript
Investor Communications View source PDF
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.1%1-day move
₹931.00
prior close
₹925.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-0.7-0.7—-4.1-6.6-6.8-8.1-9.5-9.0-2.8+0.0——
Up moveDown movePending
AI summary
Natco Pharma has submitted a transcript (likely of an earnings call or investor meeting) to the stock exchange, as required under listing rules. No specific financial numbers, guidance, or strategic updates are visible from the filing headline itself. Investors would need to read the full transcript for details on the company's performance and outlook. This is a routine regulatory disclosure rather than a material event.
Likely market impact
Neutral for the stock — a transcript submission is standard compliance disclosure and usually does not move the share price unless the underlying call contained surprising guidance or news.